Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Nivolumab Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

  • MAI4640773
  • 130 Pages
  • September 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Based on the Nivolumab market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Nivolumab market covered in Chapter 5:

Ono Pharmaceutical

Bristol-Myers Squibb

In Chapter 6, on the basis of types, the Nivolumab market from 2015 to 2025 is primarily split into:

Injection 4mL

Injection 10mL

In Chapter 7, on the basis of applications, the Nivolumab market from 2015 to 2025 covers:

Unresectable Melanoma

Metastatic Melanoma

Metastatic Squamous NSCLC

Classical Hodgkin Lymphoma

Renal Cell Carcinoma

Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Nivolumab Market Size

1.3 Market Segmentation

1.4 Global Macroeconomic Analysis

1.5 SWOT Analysis

2. Market Dynamics

2.1 Market Drivers

2.2 Market Constraints and Challenges

2.3 Emerging Market Trends

2.4 Impact of COVID-19

2.4.1 Short-term Impact

2.4.2 Long-term Impact

3 Associated Industry Assessment

3.1 Supply Chain Analysis

3.2 Industry Active Participants

3.2.1 Suppliers of Raw Materials

3.2.2 Key Distributors/Retailers

3.3 Alternative Analysis

3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

4.1 Industry Leading Players

4.2 Industry News

4.2.1 Key Product Launch News

4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

5.1 Ono Pharmaceutical

5.1.1 Ono Pharmaceutical Company Profile

5.1.2 Ono Pharmaceutical Business Overview

5.1.3 Ono Pharmaceutical Nivolumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.1.4 Ono Pharmaceutical Nivolumab Products Introduction

5.2 Bristol-Myers Squibb

5.2.1 Bristol-Myers Squibb Company Profile

5.2.2 Bristol-Myers Squibb Business Overview

5.2.3 Bristol-Myers Squibb Nivolumab Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.2.4 Bristol-Myers Squibb Nivolumab Products Introduction

6 Market Analysis and Forecast, By Product Types

6.1 Global Nivolumab Sales, Revenue and Market Share by Types (2015-2020)

6.1.1 Global Nivolumab Sales and Market Share by Types (2015-2020)

6.1.2 Global Nivolumab Revenue and Market Share by Types (2015-2020)

6.1.3 Global Nivolumab Price by Types (2015-2020)

6.2 Global Nivolumab Market Forecast by Types (2020-2025)

6.2.1 Global Nivolumab Market Forecast Sales and Market Share by Types (2020-2025)

6.2.2 Global Nivolumab Market Forecast Revenue and Market Share by Types (2020-2025)

6.3 Global Nivolumab Sales, Price and Growth Rate by Types (2015-2020)

6.3.1 Global Nivolumab Sales, Price and Growth Rate of Injection 4mL

6.3.2 Global Nivolumab Sales, Price and Growth Rate of Injection 10mL

6.4 Global Nivolumab Market Revenue and Sales Forecast, by Types (2020-2025)

6.4.1 Injection 4mL Market Revenue and Sales Forecast (2020-2025)

6.4.2 Injection 10mL Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

7.1 Global Nivolumab Sales, Revenue and Market Share by Applications (2015-2020)

7.1.1 Global Nivolumab Sales and Market Share by Applications (2015-2020)

7.1.2 Global Nivolumab Revenue and Market Share by Applications (2015-2020)

7.2 Global Nivolumab Market Forecast by Applications (2020-2025)

7.2.1 Global Nivolumab Market Forecast Sales and Market Share by Applications (2020-2025)

7.2.2 Global Nivolumab Market Forecast Revenue and Market Share by Applications (2020-2025)

7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)

7.3.1 Global Nivolumab Revenue, Sales and Growth Rate of Unresectable Melanoma (2015-2020)

7.3.2 Global Nivolumab Revenue, Sales and Growth Rate of Metastatic Melanoma (2015-2020)

7.3.3 Global Nivolumab Revenue, Sales and Growth Rate of Metastatic Squamous NSCLC (2015-2020)

7.3.4 Global Nivolumab Revenue, Sales and Growth Rate of Classical Hodgkin Lymphoma (2015-2020)

7.3.5 Global Nivolumab Revenue, Sales and Growth Rate of Renal Cell Carcinoma (2015-2020)

7.3.6 Global Nivolumab Revenue, Sales and Growth Rate of Other (2015-2020)

7.4 Global Nivolumab Market Revenue and Sales Forecast, by Applications (2020-2025)

7.4.1 Unresectable Melanoma Market Revenue and Sales Forecast (2020-2025)

7.4.2 Metastatic Melanoma Market Revenue and Sales Forecast (2020-2025)

7.4.3 Metastatic Squamous NSCLC Market Revenue and Sales Forecast (2020-2025)

7.4.4 Classical Hodgkin Lymphoma Market Revenue and Sales Forecast (2020-2025)

7.4.5 Renal Cell Carcinoma Market Revenue and Sales Forecast (2020-2025)

7.4.6 Other Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

8.1 Global Nivolumab Sales by Regions (2015-2020)

8.2 Global Nivolumab Market Revenue by Regions (2015-2020)

8.3 Global Nivolumab Market Forecast by Regions (2020-2025)

9 North America Nivolumab Market Analysis

9.1 Market Overview and Prospect Analysis

9.2 North America Nivolumab Market Sales and Growth Rate (2015-2020)

9.3 North America Nivolumab Market Revenue and Growth Rate (2015-2020)

9.4 North America Nivolumab Market Forecast

9.5 The Influence of COVID-19 on North America Market

9.6 North America Nivolumab Market Analysis by Country

9.6.1 U.S. Nivolumab Sales and Growth Rate

9.6.2 Canada Nivolumab Sales and Growth Rate

9.6.3 Mexico Nivolumab Sales and Growth Rate

10 Europe Nivolumab Market Analysis

10.1 Market Overview and Prospect Analysis

10.2 Europe Nivolumab Market Sales and Growth Rate (2015-2020)

10.3 Europe Nivolumab Market Revenue and Growth Rate (2015-2020)

10.4 Europe Nivolumab Market Forecast

10.5 The Influence of COVID-19 on Europe Market

10.6 Europe Nivolumab Market Analysis by Country

10.6.1 Germany Nivolumab Sales and Growth Rate

10.6.2 United Kingdom Nivolumab Sales and Growth Rate

10.6.3 France Nivolumab Sales and Growth Rate

10.6.4 Italy Nivolumab Sales and Growth Rate

10.6.5 Spain Nivolumab Sales and Growth Rate

10.6.6 Russia Nivolumab Sales and Growth Rate

11 Asia-Pacific Nivolumab Market Analysis

11.1 Market Overview and Prospect Analysis

11.2 Asia-Pacific Nivolumab Market Sales and Growth Rate (2015-2020)

11.3 Asia-Pacific Nivolumab Market Revenue and Growth Rate (2015-2020)

11.4 Asia-Pacific Nivolumab Market Forecast

11.5 The Influence of COVID-19 on Asia Pacific Market

11.6 Asia-Pacific Nivolumab Market Analysis by Country

11.6.1 China Nivolumab Sales and Growth Rate

11.6.2 Japan Nivolumab Sales and Growth Rate

11.6.3 South Korea Nivolumab Sales and Growth Rate

11.6.4 Australia Nivolumab Sales and Growth Rate

11.6.5 India Nivolumab Sales and Growth Rate

12 South America Nivolumab Market Analysis

12.1 Market Overview and Prospect Analysis

12.2 South America Nivolumab Market Sales and Growth Rate (2015-2020)

12.3 South America Nivolumab Market Revenue and Growth Rate (2015-2020)

12.4 South America Nivolumab Market Forecast

12.5 The Influence of COVID-19 on South America Market

12.6 South America Nivolumab Market Analysis by Country

12.6.1 Brazil Nivolumab Sales and Growth Rate

12.6.2 Argentina Nivolumab Sales and Growth Rate

12.6.3 Columbia Nivolumab Sales and Growth Rate

13 Middle East and Africa Nivolumab Market Analysis

13.1 Market Overview and Prospect Analysis

13.2 Middle East and Africa Nivolumab Market Sales and Growth Rate (2015-2020)

13.3 Middle East and Africa Nivolumab Market Revenue and Growth Rate (2015-2020)

13.4 Middle East and Africa Nivolumab Market Forecast

13.5 The Influence of COVID-19 on Middle East and Africa Market

13.6 Middle East and Africa Nivolumab Market Analysis by Country

13.6.1 UAE Nivolumab Sales and Growth Rate

13.6.2 Egypt Nivolumab Sales and Growth Rate

13.6.3 South Africa Nivolumab Sales and Growth Rate

14 Conclusions and Recommendations

14.1 Key Market Findings and Prospects

14.2 Advice for Investors

15 Appendix

15.1 Methodology

15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Nivolumab Market Size and Growth Rate 2015-2025

Table Nivolumab Key Market Segments

Figure Global Nivolumab Market Revenue ($) Segment by Type from 2015-2020

Figure Global Nivolumab Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Nivolumab

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Ono Pharmaceutical Company Profile

Table Ono Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Ono Pharmaceutical Production and Growth Rate

Figure Ono Pharmaceutical Market Revenue ($) Market Share 2015-2020

Table Bristol-Myers Squibb Company Profile

Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bristol-Myers Squibb Production and Growth Rate

Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020

Table Global Nivolumab Sales by Types (2015-2020)

Table Global Nivolumab Sales Share by Types (2015-2020)

Table Global Nivolumab Revenue ($) by Types (2015-2020)

Table Global Nivolumab Revenue Share by Types (2015-2020)

Table Global Nivolumab Price ($) by Types (2015-2020)

Table Global Nivolumab Market Forecast Sales by Types (2020-2025)

Table Global Nivolumab Market Forecast Sales Share by Types (2020-2025)

Table Global Nivolumab Market Forecast Revenue ($) by Types (2020-2025)

Table Global Nivolumab Market Forecast Revenue Share by Types (2020-2025)

Figure Global Injection 4mL Sales and Growth Rate (2015-2020)

Figure Global Injection 4mL Price (2015-2020)

Figure Global Injection 10mL Sales and Growth Rate (2015-2020)

Figure Global Injection 10mL Price (2015-2020)

Figure Global Nivolumab Market Revenue ($) and Growth Rate Forecast of Injection 4mL (2020-2025)

Figure Global Nivolumab Sales and Growth Rate Forecast of Injection 4mL (2020-2025)

Figure Global Nivolumab Market Revenue ($) and Growth Rate Forecast of Injection 10mL (2020-2025)

Figure Global Nivolumab Sales and Growth Rate Forecast of Injection 10mL (2020-2025)

Table Global Nivolumab Sales by Applications (2015-2020)

Table Global Nivolumab Sales Share by Applications (2015-2020)

Table Global Nivolumab Revenue ($) by Applications (2015-2020)

Table Global Nivolumab Revenue Share by Applications (2015-2020)

Table Global Nivolumab Market Forecast Sales by Applications (2020-2025)

Table Global Nivolumab Market Forecast Sales Share by Applications (2020-2025)

Table Global Nivolumab Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Nivolumab Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Unresectable Melanoma Sales and Growth Rate (2015-2020)

Figure Global Unresectable Melanoma Price (2015-2020)

Figure Global Metastatic Melanoma Sales and Growth Rate (2015-2020)

Figure Global Metastatic Melanoma Price (2015-2020)

Figure Global Metastatic Squamous NSCLC Sales and Growth Rate (2015-2020)

Figure Global Metastatic Squamous NSCLC Price (2015-2020)

Figure Global Classical Hodgkin Lymphoma Sales and Growth Rate (2015-2020)

Figure Global Classical Hodgkin Lymphoma Price (2015-2020)

Figure Global Renal Cell Carcinoma Sales and Growth Rate (2015-2020)

Figure Global Renal Cell Carcinoma Price (2015-2020)

Figure Global Other Sales and Growth Rate (2015-2020)

Figure Global Other Price (2015-2020)

Figure Global Nivolumab Market Revenue ($) and Growth Rate Forecast of Unresectable Melanoma (2020-2025)

Figure Global Nivolumab Sales and Growth Rate Forecast of Unresectable Melanoma (2020-2025)

Figure Global Nivolumab Market Revenue ($) and Growth Rate Forecast of Metastatic Melanoma (2020-2025)

Figure Global Nivolumab Sales and Growth Rate Forecast of Metastatic Melanoma (2020-2025)

Figure Global Nivolumab Market Revenue ($) and Growth Rate Forecast of Metastatic Squamous NSCLC (2020-2025)

Figure Global Nivolumab Sales and Growth Rate Forecast of Metastatic Squamous NSCLC (2020-2025)

Figure Global Nivolumab Market Revenue ($) and Growth Rate Forecast of Classical Hodgkin Lymphoma (2020-2025)

Figure Global Nivolumab Sales and Growth Rate Forecast of Classical Hodgkin Lymphoma (2020-2025)

Figure Global Nivolumab Market Revenue ($) and Growth Rate Forecast of Renal Cell Carcinoma (2020-2025)

Figure Global Nivolumab Sales and Growth Rate Forecast of Renal Cell Carcinoma (2020-2025)

Figure Global Nivolumab Market Revenue ($) and Growth Rate Forecast of Other (2020-2025)

Figure Global Nivolumab Sales and Growth Rate Forecast of Other (2020-2025)

Figure Global Nivolumab Sales and Growth Rate (2015-2020)

Table Global Nivolumab Sales by Regions (2015-2020)

Table Global Nivolumab Sales Market Share by Regions (2015-2020)

Figure Global Nivolumab Sales Market Share by Regions in 2019

Figure Global Nivolumab Revenue and Growth Rate (2015-2020)

Table Global Nivolumab Revenue by Regions (2015-2020)

Table Global Nivolumab Revenue Market Share by Regions (2015-2020)

Figure Global Nivolumab Revenue Market Share by Regions in 2019

Table Global Nivolumab Market Forecast Sales by Regions (2020-2025)

Table Global Nivolumab Market Forecast Sales Share by Regions (2020-2025)

Table Global Nivolumab Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Nivolumab Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Nivolumab Market Sales and Growth Rate (2015-2020)

Figure North America Nivolumab Market Revenue and Growth Rate (2015-2020)

Figure North America Nivolumab Market Forecast Sales (2020-2025)

Figure North America Nivolumab Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Canada Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Mexico Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Europe Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Europe Nivolumab Market Revenue and Growth Rate (2015-2020)

Figure Europe Nivolumab Market Forecast Sales (2020-2025)

Figure Europe Nivolumab Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Nivolumab Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Nivolumab Market Sales and Growth Rate (2015-2020)

Figure France Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Italy Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Spain Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Russia Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Nivolumab Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Nivolumab Market Forecast Sales (2020-2025)

Figure Asia-Pacific Nivolumab Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Japan Nivolumab Market Sales and Growth Rate (2015-2020)

Figure South Korea Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Australia Nivolumab Market Sales and Growth Rate (2015-2020)

Figure India Nivolumab Market Sales and Growth Rate (2015-2020)

Figure South America Nivolumab Market Sales and Growth Rate (2015-2020)

Figure South America Nivolumab Market Revenue and Growth Rate (2015-2020)

Figure South America Nivolumab Market Forecast Sales (2020-2025)

Figure South America Nivolumab Market Forecast Revenue ($) (2020-2025)

Figure Brazil Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Argentina Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Columbia Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Nivolumab Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Nivolumab Market Forecast Sales (2020-2025)

Figure Middle East and Africa Nivolumab Market Forecast Revenue ($) (2020-2025)

Figure UAE Nivolumab Market Sales and Growth Rate (2015-2020)

Figure Egypt Nivolumab Market Sales and Growth Rate (2015-2020)

Figure South Africa Nivolumab Market Sales and Growth Rate (2015-2020)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390